Leading medical devices player, Medtronic (MDT) has received approval from Health Canada for the use of its Deep Brain Stimulation (“DBS”) therapy in refractory epilepsy patients. This therapy sends controlled electrical …
Friday, March 16th, 2012 | Permalink
Leading medical devices player, Medtronic (MDT) has received approval from Health Canada for the use of its Deep Brain Stimulation (“DBS”) therapy in refractory epilepsy patients. This therapy sends controlled electrical …